Nick Routledge@nick_routledge

Reserving a special place in hell. An NYT investigation found a pattern of insiders at biotech companies selling shares shortly after announcing incremental progress on coronavirus vaccines. When their stock prices jumped, they sold $1 billion+ of stock. nytimes.com/2020/07/25/business/coronavirus-vaccine-profits-vaxart.html